Name: Interest Coverage

Definition: Interest coverage tells you how easily the company can pay interest on its debt using operating profits. It’s like asking: “Can the company comfortably make its loan payments, or is it barely scraping by?” The higher the ratio, the safer. A very low ratio means debt payments may strain the business, especially if profits drop.

Interpretation:
• In '2021', ITGR's interest coverage was 4.20, indicating the firm's ability to meet its interest obligations. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2021' stood at -0.89.
• In '2022', ITGR's interest coverage was 2.84, indicating the firm's ability to meet its interest obligations. The decline from '2021' may indicate some operational or financial challenges. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2022' stood at -0.78. Industry average increased by 0.10 compared to previous year.
• In '2023', ITGR's interest coverage was 3.15, indicating the firm's ability to meet its interest obligations. The increase since '2022' reflects strengthening financial performance. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2023' stood at 0.62. Industry average increased by 1.40 compared to previous year.
• In '2024', ITGR's interest coverage was 3.82, indicating the firm's ability to meet its interest obligations. The increase since '2023' reflects strengthening financial performance. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2024' stood at 1.50. Industry average increased by 0.88 compared to previous year.
Overall, ITGR's interest coverage has been volatile but showed a downward trend over the past 4 years.

Formula: Interest Coverage = EBIT / Interest Expense

Good Range: Minimum 3-5 desirable; below 1 is risky.